Craft

NuVasive

Revenue

$1.2 B

FY, 2022

NuVasive Summary

Company Summary

Overview
NuVasive is a medical device company that develops, manufactures, sells, and provides integrated solutions for spine surgery. It offers procedurally integrated solutions including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company provides products used to treat lumbar degenerative disc disease, lumbar spinal stenosis, degenerative spondylolisthesis, cervical disc degeneration, and other conditions.
Type
Subsidiary
Status
Active
Founded
1997
HQ
San Diego, CA, US | view all locations
Website
https://www.nuvasive.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Chris Barry

    Chris Barry, Chief Executive Officer

  • Matt Harbaugh

    Matt Harbaugh, Executive Vice President and Chief Financial Officer

  • Gabriel Ozel

    Gabriel Ozel, Chief Compliance Officer and Chief Privacy Officer

  • Elsa G. LaFarga

    Elsa G. LaFarga, VP Talent, and Chief Diversity Officer

Operating MetricsView all

Trademarks

400

FY, 2022

Facility Space Owned, sq. ft.

280K

FY, 2022

Facility Space Leased, sq. ft.

503K

FY, 2022

LocationsView all

16 locations detected

  • San Diego, CA HQ

    United States

    7475 Lusk Blvd

  • Aliso Viejo, CA

    United States

    101 Enterprise

  • Ann Arbor, MI

    United States

    3891 Ranchero Dr

  • Broomfield, CO

    United States

    12101 Airport Way

  • Columbia, MD

    United States

    10275 Little Patuxent Pkwy #300

  • Dayton, OH

    United States

    805 Liberty Ln

and 10 others

NuVasive Financials

Summary Financials

Revenue (Q2, 2023)
$317.8M
Gross profit (Q2, 2023)
$228.3M
Net income (Q2, 2023)
$7.4M
Cash (Q2, 2023)
$80.7M

Footer menu